The conversion of mRNA to proteins, is the cornerstone of gene expression

Translation, the conversion of mRNA to proteins, is the cornerstone of gene expression. Understanding global translation rates is critical for exploring cellular adaptation, protein synthesis efficiency, and disease mechanisms. While traditional transcriptomics provides mRNA abundance, it cannot capture the nuances of translation dynamics. This is where Polysome-Seq revolutionises research by directly linking mRNA association with ribosomes to translational output.

Polysome-Seq measures translation rates by fractionating mRNAs based on ribosome association, providing a quantitative view of ribosome density and mRNA engagement. It enables researchers to explore translational efficiency, codon usage, and ribosome stalling, offering unparalleled insights into the molecular basis of gene expression.

How Polysome-Seq Works

Polysome-Seq integrates polysome profiling with RNA sequencing. The method involves separating mRNAs using sucrose gradient centrifugation to distinguish transcripts with different ribosome loads. RNA from these fractions is sequenced to evaluate ribosome density and determine translation efficiency. This approach categorises mRNAs into:

  • Light fractions: 1-3 ribosomes per transcript, representing low translation activity.
  • Heavy fractions: >3 ribosomes per transcript, indicating high translation activity.

The flexibility of Polysome-Seq allows for customised fraction collection, enabling detailed exploration of translational states.

Applications of Polysome-Seq in Global Translation Rates

1. Quantifying Translational Efficiency

Polysome-Seq provides a direct measurement of ribosome density, revealing the efficiency of translation across the transcriptome. This application is essential for:

  • Comparing translation rates between conditions (e.g., disease vs. normal states).
  • Investigating how environmental factors influence translation.
  • Exploring translational control mechanisms in therapeutic contexts.

By mapping ribosome density, Polysome-Seq uncovers patterns in ribosome association, such as:

  • Ribosome pausing: Translational stalling at specific codons or sequences.
  • Optimal ribosome loading: Identifying codons and untranslated regions (UTRs) that maximise translation.

Diseases such as cancer and neurodegenerative disorders often involve dysregulated translation. Polysome-Seq helps identify translational signatures associated with these conditions, providing targets for therapeutic intervention.

Polysome-Seq vs Other Methods

While ribosome profiling captures ribosome-protected mRNA fragments at sub-codon resolution, Polysome-Seq offers distinct advantages for studying global translation rates:

  • Broader View: Polysome-Seq provides longer RNA reads, enabling isoform-specific analysis.
  • Quantitative Insights: Measures translational activity directly through ribosome density.
  • Scalability: Adaptable fraction collection allows for detailed or high-level exploration.

Overcoming Challenges in Polysome-Seq

Technical Expertise

Polysome profiling requires ultracentrifugation and careful fractionation for accurate results. EIRNA Bio’s team employs optimised sucrose gradient protocols to ensure reliability and reproducibility.

Data Complexity

The high volume of data generated necessitates advanced bioinformatics for meaningful interpretation. EIRNA Bio-Connect simplifies analysis with tools for normalising ribosome density, comparing translational efficiencies, and visualising transcript profiles.

Resource Intensity

Ultracentrifugation equipment and reagents are costly for many labs. Partnering with EIRNA Bio eliminates these barriers, delivering tailored solutions to accelerate research.

EIRNA Bio’s Expertise in Polysome-Seq

EIRNA Bio is at the forefront of translatomics, offering expertise in Polysome-Seq to support a range of research goals. Our services include:

  • High-Quality Data Generation: From library preparation to sequencing, we deliver reliable results.
  • Customisable Protocols: Tailored approaches to meet diverse experimental needs.
  • Advanced Analysis: Comprehensive bioinformatics support with the EIRNA Bio-Connect platform.

Use Cases for Global Translation Rate Analysis

1. Drug Discovery

Polysome-Seq accelerates drug development by revealing how candidate drugs impact translation. It identifies:

  • Off-target effects on ribosome association. 
  • Translational biomarkers for monitoring therapeutic responses.

By optimising translation of therapeutic genes, Polysome-Seq enhances the efficacy of gene therapies. It evaluates codon usage, UTRs, and RNA modifications to maximise protein output.

Translational signatures uncovered by Polysome-Seq serve as biomarkers for diseases, enabling precise diagnosis and personalised treatments.

Interactive Bioinformatics with EIRNA Bio-Connect

EIRNA Bio-Connect transforms complex datasets into actionable insights. Its features include:

  • Dynamic Visualisations: Explore ribosome density and translational efficiency across conditions.
  • Customised Analyses: Tailored pipelines for comparing translational profiles.
  • Comprehensive Insights: Evaluate how codon usage, UTRs, and mRNA features influence translation.

Why Choose EIRNA Bio for Polysome-Seq?

EIRNA Bio’s Polysome-Seq services provide unmatched precision and flexibility. By integrating expert protocols with advanced analysis tools, we empower researchers to uncover the complexities of global translation rates. Whether for basic research or therapeutic development, EIRNA Bio is your partner in translational science.

Explore how Polysome-Seq can enhance your understanding of global translation rates. Contact Us Today

contact form image

Are you ready to book an appointment now!